What meta[bolic] does

meta[bolic], operating legally as GluCare Integrated Diabetes Center L.L.C., is a Dubai-based digital therapeutics and hybrid care provider focused on metabolic disease management, primarily diabetes, obesity, and related endocrine conditions. The company delivers care through a hybrid model that combines in-person clinical consultations at its Dubai clinics (Jumeirah and Al Barsha, with a third location at Dubai Digital Park coming soon) with Continuous Remote Data Monitoring (RCDM), a proprietary technology platform that captures glucose readings, food logs, activity, medication titration, and sleep data for real-time review by a multidisciplinary care team of physicians, dietitians, diabetes educators, coaches, and physiotherapists. The technology stack integrates CGM devices (Dexcom G7, Medtronic MiniMed 780G, Omnipod 5), AI-driven diagnostics (Prism 3D body composition scanning, AI muscle ultrasound, Amplifai TFScan thermal imaging, Shosabi AI fitness, ECAL indirect calorimetry), wearable integrations (Oura Ring), and an AI-powered patient app with food logging and 24/7 care team chat.

The company monetizes through tiered monthly subscription programs (Basic AED 595–749/month, Comprehensive AED 995–1,249/month), multi-month weight loss program subscriptions (AED 3,500–7,200 for 3–12 month commitments), standalone medication sales (GLP-1s, peptides), a la carte clinical services (physiotherapy, RFA thyroid ablation, ESWT, Tonal strength training), peptide protocols (AED 2,750–9,500 per cycle), corporate B2B health solutions via business.metabolic.health, and an e-commerce storefront at shop.metabolic.health. Distribution combines direct-to-patient clinic access with broad UAE insurance network coverage (GlobeMed, NAS, Saico Health, NextCare, and others) and payment-plan financing via Tamara/Tabby. The company reports serving 2,310 patients across diabetes, prediabetes, and obesity programs, publishes clinical outcomes (including 18.43% HbA1c reduction and 25% HbA1c reduction in 3 months, 12.3 kg average weight loss in 9 months, 81% prediabetes reversal at 3 months), and holds the world's first globally ICHOM-accredited facility status (2022) along with CAP, JCI, URAC, and HIPAA certifications. International expansion into London (1 Knightsbridge) and the United States is underway, funded by a strategic growth capital facility from RAKBANK closed in February 2026.

Name

meta[bolic]

Legal name

GluCare Integrated Diabetes Center L.L.C.

Website

https://metabolic.health

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

meta[bolic] is a Dubai-based hybrid-care provider offering technology-enabled, outcomes-accountable management of diabetes, obesity, and related endocrine conditions through subscription programs, proprietary continuous remote monitoring, AI-driven diagnostics, and a multidisciplinary in-clinic care team, now expanding to the UK and US.

Ownership category

akta.pro rank

Product category

Digital Therapeutics & Hybrid Metabolic Care

NAICS

Diet and Weight Reducing Centers (812191), Pharmacies and Drug Retailers (456110), Food (Health) Supplement Retailers (456191)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

akta.pro secondary industries

Diabetes (General) (HLAKADAA), Obesity Medicine & Weight Management (HLAKADAL), Diabetes Education & Insulin Management (Home-Based) (HSABACAJ), Endocrinology & Metabolic Specialty Pharmaceuticals (HLAIACAD), Diabetes & Blood Sugar Nutrition Coaching (HSADAFAF)

Keywords

• Metabolic health services
• Diabetes management programs
• Medical weight loss
• Digital therapeutics
• Remote patient monitoring

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Subscription Plans (Insurance-Covered and Self-Pay): Monthly subscription programs covering consultations, remote monitoring, lab tests, body composition scans, CGM devices, and care team access. Insurance-covered plans for insured patients; self-pay subscription plans (Basic and Comprehensive tiers) for uninsured patients starting at AED 595-995/month. Subscription terms range from 3 to 12 months with discounts for upfront payment.
2. Medication Sales: Sale of GLP-1 medications (Ozempic, Mounjaro, Wegovy, Rybelsus), insulin, peptides (Ipamorelin+CJC-1295, Tesamorelin, BPC-157, TB-500, etc.), and other therapeutics through on-site pharmacy and e-commerce shop (shop.metabolic.health). Peptide protocols sold as bundled cycles (AED 2,750-9,500 per cycle).
3. Professional Services and Procedures: A la carte professional services including physiotherapy sessions (AED 285/session or bundled packages), Tonal strength training sessions (AED 300/session), dietitian consultations, and specialized procedures such as Radiofrequency Thyroid Ablation (RFA) and ESWT (Extracorporeal Shockwave Therapy for erectile dysfunction).
4. Weight Loss Program Subscriptions: Structured weight loss program subscriptions with tiered pricing based on commitment length (3/6/9/12 months). Includes physician consultations, CGM, coaching, body composition analysis, dietitian sessions, and add-on packages (Tonal, EMS, physiotherapy). Medication priced separately.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

meta[bolic] is a Dubai-based hybrid metabolic care provider that delivers physician-led clinical programs for diabetes, prediabetes, obesity, thyroid disorders, hormonal conditions (TRT/HRT), peptides, and pediatric endocrinology. Care combines in-clinic consultations at Dubai clinics with a proprietary Continuous Remote Data Monitoring (RCDM) platform that streams glucose, food, activity, medication, and sleep data for real-time multidisciplinary review. Revenue is generated through monthly subscription plans (Basic and Comprehensive Diabetes tiers, tiered Weight Loss Programs), a la carte procedures (Tonal, EMS, physiotherapy, dietitian, RFA thyroid ablation, ESWT), an on-site pharmacy and online shop selling GLP-1 medications and peptide therapies, and B2B employer-sponsored corporate health packages.

Product overview

Metabolic.Health is a Dubai-based healthcare company operating a technology-enabled hybrid care model for metabolic disease management. The company offers a unified platform combining in-person clinical services with continuous remote data monitoring, organized across three main sub-brands: GluCare.Health (diabetes management), Zone.Health (weight loss), and the main Metabolic.Health brand (comprehensive metabolic services). Core offerings include Diabetes Management Programs (Type 1, Type 2, prediabetes, gestational, rare types), Weight Loss Programs using GLP-1 medications, Thyroid Services, Peptide Therapy, Hormone Replacement Therapy, TRT, PMOS Management, and Pediatric Endocrinology services. The technology stack includes proprietary Continuous Remote Data Monitoring (RCDM), AI-powered diagnostics (Prism 3D body scanning, AI muscle ultrasound, Amplifai TFScan), connected medical devices (Dexcom G7, Medtronic pumps, Omnipod 5), and metabolic assessment tools (ECAL, Shosabi). Subscription plans provide unlimited access to consultations, CGM devices, and the integrated patient platform. The company is expanding internationally to UK (London) and US markets following RAKBANK growth capital investment.

Differentiator

Problem solved

Functional benefit

Products and services

• Diabetes Management Program Comprehensive care for Type 1, Type 2, gestational, prediabetes, and rare/monogenic diabetes (MODY, LADA, neonatal) combining continuous glucose monitoring, insulin pump therapy, medication management, dietitian support, and 24/7 care team access. Reported outcome: 25% HbA1c reduction in 3 months.
• Unlimited Diabetes Subscription Program Monthly subscription with Basic (AED 595-749/mo) and Comprehensive (AED 995-1,249/mo) tiers covering unlimited consultations, quarterly blood panels, body composition analysis, dietitian sessions, medication refill consults, CGM (Dexcom G7), Medtronic 780G insulin pump for eligible Type 1 patients, and integrated app access. Insurance-covered or self-pay.
• Weight Loss Program Comprehensive obesity program combining GLP-1 medications (Ozempic, Mounjaro, Wegovy, Rybelsus, Foundayo/orforglipron) with Prism body composition scanning, AI muscle ultrasound, ECAL indirect calorimetry, Shosabi fitness AI, physiotherapy, and Tonal smart resistance training. Reported outcomes: 12.3kg average weight loss in 9 months with 80% fat preservation.
• Weight Loss Subscription Plans Tiered subscription commitments priced at AED 3,500 (3 months), AED 5,000 (6 months), AED 6,200 (9 months), and AED 7,200 (12 months) including physician consultations, CGM integration, coaching, body composition analysis, Shosabi fitness assessment, Prism scan, ECAL indirect calorimetry, Tonal sessions (12 credits for 6-month plan), dietitian sessions, and personalized workout plan. Medication priced separately.
• Thyroid Services Comprehensive thyroid disorder management including AI-assisted ultrasound for nodule/cancer screening, Radiofrequency Thyroid Ablation (RFA) for benign nodules and select recurrent cancers, T3+T4 combination therapy for persistent hypothyroid symptoms, and Hashimoto's/Graves' autoimmune care. Reports ~50% reduction in unnecessary procedures.
• Peptide Therapy Outcome-based peptide protocols including Metabolic Health bundle (Ipamorelin + CJC-1295, Tesamorelin, MOTS-C, Kisspeptin) at AED 9,500/6-week cycle, Longevity & Anti-ageing (Epitalon) at AED 2,750/3-week cycle, and Healing & Immunity (TB-500, BPC-157, Thymosin alpha-1, GHK-Cu) at AED 5,700/4-6 week cycle. Includes pre/post biomarker testing.
• Hormone Replacement Therapy (HRT) Advanced hormone replacement therapy for perimenopause, menopause, and hormonal deficiencies integrating lifestyle tracking via Oura Ring with lab tests and medication management. Reported benefits: 30% reduction in cardiovascular disease risk, 70% reduction in mood swings/sleep disturbances, 10% bone density improvement.
• Testosterone Replacement Therapy (TRT) TRT program offering baseline tests, multiple medication options (Nebido, Sustanon, Depo-Testosterone, Testogel, compounded cream, hCG for fertility preservation), at-home service, and continuous virtual support. Self-pay pricing AED 3,500 (3-month) to AED 6,750 (12-month commitment). Insurance-covered option available.
• PMOS Management Program PMOS (formerly PCOS) treatment combining endocrinology and gynaecology with Oura Ring integration for cycle tracking, period prediction, and metabolic monitoring. Includes comprehensive hormone and metabolic testing covered by insurance.
• Pediatric Endocrinology Services Specialized pediatric endocrinology (0-18 years) covering diabetes (Type 1, Type 2, MODY), obesity (Wegovy for ages 12+), growth hormone therapy, thyroid disorders, bone and calcium disorders, adrenal disorders, and adolescent endocrinology. Insurance-covered with wearable-enabled continuous monitoring.
• Pediatric Growth Hormone Program Quarterly subscription (AED 2,195/quarter) for pediatric growth hormone therapy including expert consultations, advanced diagnostics, personalized GH therapy, at-home medication delivery, and concierge support. Medication and MRI costs excluded.
• Pediatric Type 1 Diabetes Program Pediatric Type 1 diabetes management with child-friendly clinic environment, 30-minute in-house lab testing, CGM integration, and dedicated pediatric diabetes team. Family-centered care with continuous remote monitoring.
• Pediatric Obesity Program Childhood obesity treatment using FDA-approved Wegovy GLP-1 medication for ages 12+, with pediatric endocrinologist oversight, unlimited physician consultations, monthly body composition scans, and multidisciplinary support from dietitians and personal trainers.
• Gestational Diabetes Care Gestational diabetes management with regular glucose monitoring, pregnancy-specific nutritional guidance, safe medication and insulin support, and postpartum diabetes risk assessment. Screening typically conducted between 24th and 28th weeks.
• Rare Types of Diabetes Care Specialized management for MODY (Maturity Onset Diabetes of the Young), LADA (Latent Autoimmune Diabetes in Adults), steroid-induced diabetes, and Type 3c (pancreatogenic) diabetes. Includes genetic testing for MODY diagnosis. Positions itself to address the 80% global misdiagnosis rate of MODY cases.
• Metabolic Baseline (Preventive Health Screening) Comprehensive 360-degree preventive screening including consultation, body composition analysis, abdominal ultrasound, ECG, AI liver elastography, retinopathy screening, and extensive lab panel. Self-pay AED 2,000; insurance discount may apply. Optional GLP-1 microdosing protocol for proactive prevention.
• p-Tau217 Alzheimer's Screening Blood-based biomarker test for early Alzheimer's detection offered as standard screening for high-risk metabolic patients (diabetics, metabolic syndrome). First healthcare provider globally to offer this test as standard care. Performance comparable to PET scans.
• uPTM-FetA Diabetic Kidney Disease Test First-in-region uPTM-FetA urine test for early detection of diabetic kidney disease (DKD). Detects kidney function decline years before conventional markers (eGFR/ACR), enabling earlier preventive therapies. Integrated into the standard diabetes care package.
• Radiofrequency Thyroid Ablation (RFA) Minimally invasive, ultrasound-guided procedure for treating benign thyroid nodules and select recurrent thyroid cancers. Preserves thyroid function through targeted tissue ablation. Outpatient procedure with return to normal activities within 24 hours.
• ESWT Erectile Dysfunction Treatment Extracorporeal Shockwave Therapy for erectile dysfunction targeting the root cause by improving blood flow and vascular health. Addresses diabetes-related sexual health complications affecting over 50% of diabetic men.

Named customers7 records

Segments7 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration12 records

AI capability12 records

Feature10 records

Partnerships

Four partnerships are on record, tiered core.

• Eli Lilly (Foundayo/Orforglipron)coreTechnology or Integration · 6 April 2026Metabolic became one of the earliest providers globally and the first in the region to offer access to Foundayo (orforglipron), Eli Lilly's newly FDA-approved daily oral GLP-1 treatment for obesity. The medication eliminates injection requirements and food/water timing restrictions. Positioned as maintenance option for patients transitioning off injectable therapies. Supplies expected in early May 2026.
• MedtroniccoreTechnology or IntegrationExclusive partnership making Medtronic MiniMed 780G insulin pump available at Metabolic's Type 1 diabetes program. The pump (worth AED 40,000) is included in the subscription plan for eligible self-pay patients who commit to 4-year usage and monthly consumables purchases. System automatically adjusts insulin delivery every 5 minutes.
• DexcomcoreTechnology or IntegrationContinuous Glucose Monitor (CGM) device partnership providing Dexcom G7 CGM for real-time glucose tracking as part of subscription programs. Dexcom G7 devices included in diabetes subscription plans.
• Insurance Network Partners (GlobeMed, NAS, Saico Health, NextCare, and others)coreChannel Partner/ Reseller/ DistributorPartnership with major UAE insurance providers enabling covered access to Metabolic's programs. Includes GlobeMed, NAS (multiple tiers: Comprehensive Plus, Farid Gold, Farid GN+, Diamond, Emerald, Sapphire, Pearl, Ruby, Empire, Gold Network, VIP), Saico Health, NextCare, Neuron, MSH, Aspire, Daman, Al Hadalla, Al Buhaira, Medinet, GIG, MetLife, and Enaya. Insurance covers consultations, lab tests, scans, and clinical programs for eligible plan members.

Scale indicators9 records

Recent moves7 records

Expansion highlights8 records

Direct peers

• Ro: Telehealth provider with a large GLP-1 weight-loss business and integrated pharmacy, comparable to Metabolic's subscription plus medication-sale model.
• Virta Health: US telehealth company delivering evidence-based diabetes and metabolic reversal with continuous remote monitoring and outcomes reporting, directly mirroring Metabolic's outcomes-accountable diabetes model.
• Noom: Behavioral weight-management and metabolic health platform now offering GLP-1 telehealth, competing with Metabolic's medicated weight-loss subscriptions.
• Omada Health: Digital chronic-care provider for diabetes, prediabetes and obesity using connected devices, coaching and RPM, closely comparable to Metabolic's hybrid metabolic care platform.
• Calibrate: US metabolic health and medically-supervised weight-loss program combining GLP-1 medications with coaching and monitoring, overlapping with Metabolic's Zone.Health weight-loss offering.

Emerging players

• Levels Health: Metabolic health company using CGM and data to guide behavior and prevention, overlapping with Metabolic's preventive/metabolic-monitoring segment.

Regional players

• Alma Health: UAE-based chronic-disease management and digital pharmacy platform serving diabetes and cardiometabolic patients, a regional peer operating in Metabolic's home market.
• Fitterfly: India-based diabetes and metabolic digital therapeutics company combining CGM, coaching and app-based programs, similar in model but serving a different geography.

Broad incumbents

• Teladoc Health (Livongo): Large virtual-care incumbent whose Livongo chronic-condition management (diabetes, hypertension) uses connected devices and coaching, overlapping with Metabolic's RPM chronic-care approach at greater scale.
• Hims & Hers Health: Broad direct-to-consumer telehealth and pharmacy platform including weight-loss/GLP-1 and hormone therapies, overlapping across several of Metabolic's service lines but with a wider portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Glucare.Health1
• LinkedInlinkedin.com/company/metabolichealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about meta[bolic]